With compounded products, patients report accidentally taking 10-times the recommended dose due to confusing measurement units while using a syringe
Table 2 Summary of the main studies with GLP1-AR
Qatar genome: Insights on genomics from the Middle East
Obesity is a complex metabolic disease
GIP Glucose-dependent insulinotropic polypeptide The GLP-1 medications Saxenda (liraglutide) and Wegovy (semaglutide) use just one mechanism of action, that is, they activate GLP-1 receptors and cause all of the above effects on appetite regulation and body weight
Downstream effectors of mTOR including hypoxia-induced factor-1 (HIF-1), hexokinase (HK), pyruvate kinase M2 (PKM2), and enolase2 will then directly stimulate aerobic glycolysis and inhibit oxidative phosphorylation in cancer cells, thus leading to the metabolic reprogramming in PDA tissue (Iqbal et al., 2013